PS
Parbhat Singh
About Parbhat Singh
Data last updated:
Parbhat Singh is a Director at Fido Pharma Private Limited (since 2020), Director at Meibotan Private Limited (since 2022) and Director at Kenu Biopharma Private Limited (since 2023). The companies operate in Chemicals and Materials, Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹20.59 Cr; the largest is Fido Pharma Private Limited at ₹20.59 Cr (FY 2024). Earlier, Parbhat Singh was a Director at Actiniq Remedies Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fido Pharma Private Limited U24230HR2020PTC085725 | Director | 04 Mar 2020 | 2020 | ₹20.59 Cr (FY 2024) | Active |
 Meibotan Private Limited U24100HR2022PTC104313 | Director | 13 Jun 2022 | 2022 | ₹10,880 (FY 2024) | Active |
| Kenu Biopharma Private Limited U21001HR2023PTC116427 | Director | 09 Nov 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Actiniq Remedies Private Limited U24230HR2021PTC095218 | Director | 24 May 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Parbhat Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ritu Raj Singh | 10186291 | Fido Pharma Private Limited | Director |
| Tejal Ashok Vispute | 08717158 | Fido Pharma Private Limited , Meibotan Private Limited | Director |
| Kuldeep Singh | 10388132 | Kenu Biopharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parbhat Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parbhat Singh
Parbhat Singh currently holds 3 directorships: Fido Pharma Private Limited (Director, since 04 Mar 2020, revenue ₹20.59 Cr (FY 2024)); Meibotan Private Limited (Director, since 13 Jun 2022, revenue ₹10,880 (FY 2024)); Kenu Biopharma Private Limited (Director, since 09 Nov 2023).
Parbhat Singh was first appointed on 04 Mar 2020 as Director at Fido Pharma Private Limited. The most recent appointment on record is 09 Nov 2023 at Kenu Biopharma Private Limited.
The 2 current companies of Parbhat Singh that report revenue have a combined latest revenue of ₹20.59 Cr: Fido Pharma Private Limited ₹20.59 Cr (FY 2024); Meibotan Private Limited ₹10,880 (FY 2024).
Parbhat Singh held 1 earlier board appointment: Actiniq Remedies Private Limited (Director, from 24 May 2021).
The current boards of Parbhat Singh's companies include Ritu Raj Singh (Fido Pharma Private Limited), Tejal Ashok Vispute (Fido Pharma Private Limited), Kuldeep Singh (Kenu Biopharma Private Limited).